Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma

Biochemical Pharmacology

Volumn 70, Issue 11, 2005, Pages 1673-1684

  Li, Bin ^a   Sedlacek, Meghan ^a   Manoharan, Indumathi ^b   Boopathy, Rathnam ^b   Duysen, Ellen G ^a   Masson, Patrick ^c   Lockridge, Oksana ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b BHARATHIAR UNIVERSITY   (India)

^c CENTRE DE RECHERCHES   (France)

Author keywords

Acetylcholinesterase; Albumin; Aspirin; Butyrylcholinesterase knockout mice; Carboxylesterase; Cocaine esterase; Human plasma; Irinotecan; Mivacurium; Paraoxonase; Procaine; Succinylcholine

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ALBUMIN ESTERASE; ARYLDIALKYLPHOSPHATASE; BAMBUTEROL; CARBOXYLESTERASE; CHLOROPROCAINE; CHOLINESTERASE; COCAINE; COMPACTIN; DIAMORPHINE; DISULFIRAM; DYFLOS; ECOTHIOPATE; ESTERASE; FLESTOLOL; IRINOTECAN; ISOSORBIDE; METHYLPREDNISOLONE ACETATE; MEVINOLIN; MIVACURIUM; MOXISYLYTE; PARAOXON; PROCAINE; SARIN; SIMVASTATIN; SPIRONOLACTONE; SUXAMETHONIUM; TETRACAINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CAT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; EXPERIMENTAL ANIMAL; HORSE; HUMAN; HYDROLYSIS; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; RABBIT; TIGER; WILD TYPE;

ACETYLCHOLINESTERASE; ALBUMINS; ANIMALS; ARYLDIALKYLPHOSPHATASE; BUTYRYLCHOLINESTERASE; CARBOXYLESTERASE; CHOLINESTERASE INHIBITORS; HUMANS; MICE; MICE, KNOCKOUT; PHOSPHORIC ACID ESTERS; SENSITIVITY AND SPECIFICITY;

EID: 27544478172     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.09.002     Document Type: Article

References (92)

1. W. Kalow, and N. Staron On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers Can J Med Sci 35 12 1957 1305 1320
2. W. Kalow, and D.M. Grant Pharmacogenetics vol. I 1995 McGraw-Hill NY
3. R.L. Souza, L.R. Mikami, R.O. Maegawa, and E.A. Chautard-Freire-Maia Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample Mol Genet Metab 84 4 2005 349 353
4. C.A. Abbott, M.I. Mackness, S. Kumar, A.O. Olukoga, C. Gordon, and S. Arrol Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus Clin Sci (Lond) 85 1 1993 77 81
5. M. Cucuianu, T. Nistor, N. Hancu, P. Orbai, C. Muscurel, and I. Stoian Serum cholinesterase activity correlates with serum insulin, C-peptide and free fatty acids levels in patients with type 2 diabetes Rom J Intern Med 40 1-4 2002 43 51
6. V.M. Alcantara, E.A. Chautard-Freire-Maia, M. Scartezini, M.S. Cerci, K. Braun-Prado, and G. Picheth Butyrylcholinesterase activity and risk factors for coronary artery disease Scand J Clin Lab Invest 62 5 2002 399 404
7. T. Gesztes Prolonged apnoea after suxamethonium injection associated with eye drops containing an anticholinesterase agent Br J Anaesth 38 5 1966 408 409
8. D.S. McGehee, M.D. Krasowski, D.L. Fung, B. Wilson, G.A. Gronert, and J. Moss Cholinesterase inhibition by potato glycoalkaloids slows mivacurium metabolism Anesthesiology 93 2 2000 510 519
9. G.E. Means, and H.L. Wu The reactive tyrosine residue of human serum albumin: characterization of its reaction with diisopropylfluorophosphate Arch Biochem Biophys 194 2 1979 526 530
10. Y. Sakurai, S.F. Ma, H. Watanabe, N. Yamaotsu, S. Hirono, and Y. Kurono Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substrates Pharm Res 21 2 2004 285 292
11. H. Watanabe, S. Tanase, K. Nakajou, T. Maruyama, U. Kragh-Hansen, and M. Otagiri Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity Biochem J 349 Pt 3 2000 813 819
12. N. Hagag, E.R. Birnbaum, and D.W. Darnall Resonance energy transfer between cysteine-34, tryptophan-214, and tyrosine-411 of human serum albumin Biochemistry 22 10 1983 2420 2427
13. S.B. Tove The esterolytic activity of serum albumin Biochim Biophys Acta 57 1962 230 235
14. A. Awad-Elkarim, and G.E. Means The reactivity of p-nitrophenyl acetate with serum albumins Comp Biochem Physiol B 91 2 1988 267 272
15. N. Ahmed, D. Dobler, M. Dean, and P.J. Thornalley Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity J Biol Chem 280 7 2005 5724 5732
16. A. Salvi, P.A. Carrupt, J.M. Mayer, and B. Testa Esterase-like activity of human serum albumin toward prodrug esters of nicotinic acid Drug Metab Dispos 25 4 1997 395 398
17. M.A. Sogorb, N. Diaz-Alejo, M.A. Escudero, and E. Vilanova Phosphotriesterase activity identified in purified serum albumins Arch Toxicol 72 4 1998 219 226
18. E.G. Erdos, and L.E. Boggs Hydrolysis of paraoxon in mammalian blood Nature 190 1961 716 717
19. K. Yoshida, Y. Kurono, Y. Mori, and K. Ikeda Esterase-like activity of human serum albumin. V. Reaction with 2,4-dinitrophenyl diethyl phosphate Chem Pharm Bull (Tokyo) 33 11 1985 4995 5001
20. U. Kragh-Hansen, V.T. Chuang, and M. Otagiri Practical aspects of the ligand-binding and enzymatic properties of human serum albumin Biol Pharm Bull 25 6 2002 695 704
21. F. Sanger Amino acid sequences in the active centers of certain enzymes Proc Chem Soc 5 1963 76 83
22. L.M. Schopfer, M.M. Champion, N. Tamblyn, C.M. Thompson, and O. Lockridge Characteristic mass spectral fragments of the organophosphorus agent FP-biotin and FP-biotinylated peptides from trypsin and bovine albumin (Tyr 410) Anal Biochem 345 2005 122 132
23. E.G. Duysen, J.A. Stribley, D.L. Fry, S.H. Hinrichs, and O. Lockridge Rescue of the acetylcholinesterase knockout mouse by feeding a liquid diet: phenotype of the adult acetylcholinesterase deficient mouse Brain Res Dev Brain Res 137 1 2002 43 54
24. Li B, Duysen EG, Saunders TL, Lockridge O. Production of the butyrylcholinesterase knockout mouse. Adv Exp Med Biol.
25. O. Lockridge, L.M. Schopfer, G. Winger, and J.H. Woods Large scale purification of butyrylcholinesterase from human plasma suitable for injection into monkeys: a potential new therapeutic for protection against cocaine and nerve agent toxicity J Med Chem Biol Radiol Defense 3 2005 [online publication]
26. M.J. Karnovsky, L. Roots, and A "direct-coloring" thiocholine method for cholinesterases J Histochem Cytochem 12 1964 219 221
27. C.E. Furlong, R.J. Richter, C. Chapline, and J.W. Crabb Purification of rabbit and human serum paraoxonase Biochemistry 30 42 1991 10133 10140
28. M. Hashinotsume, K. Higashino, T. Hada, and Y. Yamamura Purification and enzymatic properties of rat serum carboxylesterase J Biochem (Tokyo) 84 6 1978 1325 1333
29. D.M. Maxwell, C.N. Lieske, and K.M. Brecht Oxime-induced reactivation of carboxylesterase inhibited by organophosphorus compounds Chem Res Toxicol 7 3 1994 428 433
30. E.S. Peeples, L.M. Schopfer, E.G. Duysen, R. Spaulding, T. Voelker, and C.M. Thompson Albumin, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry Toxicol Sci 83 2 2005 303 312
31. G.L. Ellman, K.D. Courtney, V. Andres Jr., and R.M. Feather-Stone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem Pharmacol 7 1961 88 95
32. D.J. Ecobichon, and W. Kalow Properties and classification of the soluble esterases of human liver Biochem Pharmacol 11 1962 573 583
33. J.E. Casida, and K.B. Augustinsson Reaction of plasma albumin with 1-naphthyl N-methylcarbamate and certain other esters Biochim Biophys Acta 36 1959 411 426
34. A.R. Hess, R.W. Angel, K.D. Barron, and J. Bernsohn Proteins and isozymes of esterases and cholinesterases from sera of different species Clin Chim Acta 19 1963 656 667
35. S. Brimijoin, and P. Hammond Butyrylcholinesterase in human brain and acetylcholinesterase in human plasma: trace enzymes measured by two-site immunoassay J Neurochem 51 4 1988 1227 1231
36. K. Sorensen, U. Brodbeck, A.G. Rasmussen, and B. Norgaard-Pedersen Normal human serum contains two forms of acetylcholinesterase Clin Chim Acta 158 1 1986 1 6
37. J. Saez-Valero, P.L. Tornel, E. Munoz-Delgado, and C.J. Vidal Amphiphilic and hydrophilic forms of acetyl- and butyrylcholinesterase in human brain J Neurosci Res 35 6 1993 678 689
38. N.E. Simpson Polyacrylamide electrophoresis used for the detection of C5+ cholinesterase in Canadian Caucasians, Indians, and Eskimos Am J Hum Genet 24 3 1972 317 320
39. A. Saxena, R.S. Hur, C. Luo, and B.P. Doctor Natural monomeric form of fetal bovine serum acetylcholinesterase lacks the C-terminal tetramerization domain Biochemistry 42 51 2003 15292 15299
40. T. Matsubara, and I. Horikoshi Spontaneous reactivation of mouse plasma cholinesterase after inhibition by various organophosphorus compounds J Pharmacobiodyn 7 5 1984 322 328
41. E. Kaliste-Korhonen, K. Tuovinen, and O. Hanninen Interspecies differences in enzymes reacting with organophosphates and their inhibition by paraoxon in vitro Hum Exp Toxicol 15 12 1996 972 978
42. G.B. Quistad, R. Klintenberg, and J.E. Casida Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants Toxicol Sci 86 2 2005 291 299
43. N.L. Anderson, M. Polanski, R. Pieper, T. Gatlin, R.S. Tirumalai, and T.P. Conrads The human plasma proteome: a nonredundant list developed by combination of four separate sources Mol Cell Proteomics 3 4 2004 311 326
44. B. Muthusamy, G. Hanumanthu, S. Suresh, B. Rekha, D. Srinivas, and L. Karthick Plasma proteome database as a resource for proteomics research Proteomics 5 13 2005 3531 3536
45. A.A. Guemei, J. Cottrell, R. Band, H. Hehman, M. Prudhomme, and M.V. Pavlov Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan Cancer Chemother Pharmacol 47 4 2001 283 290
46. K. Shirai, I. Ohsawa, Y. Ishikawa, Y. Saito, and S. Yoshida Human plasma carboxyl esterase-catalyzed triolein hydrolysis. Existence of promoting factor in serum J Biol Chem 260 9 1985 5225 5227
47. K. Shirai, I. Ohsawa, Y. Saito, and S. Yoshida Effects of phospholipids on hydrolysis of trioleoylglycerol by human serum carboxylesterase Biochim Biophys Acta 962 3 1988 377 383
48. T. Satoh, and M. Hosokawa The mammalian carboxylesterases: from molecules to functions Annu Rev Pharmacol Toxicol 38 1998 257 288
49. L.V. Albers, S. Dray, and K.L. Knight Allotypes and isozymes of rabbit alpha-1-aryl esterase. Allelic products with different enzymatic acitivities for the same substrates Biochemistry 8 11 1969 4416 4424
50. W.N. Aldridge, and I. Serum esterases Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination Biochem J 53 1 1953 110 117
51. A. Smolen, H.W. Eckerson, K.N. Gan, N. Hailat, and B.N. La Du Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase Drug Metab Dispos 19 1 1991 107 112
52. G. Leng, J. Lewalter, B. Rohrig, and H. Idel The influence of individual susceptibility in pyrethroid exposure Toxicol Lett 107 1-3 1999 123 130
53. Morton CL, Iacono L, Hyatt JL, Taylor KR, Cheshire PJ, Houghton PJ, et al. Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice. Cancer Chemother Pharmacol 2005; in press.
54. K.B. Augustinsson Multiple forms of esterase in vertebrate blood plasma Ann NY Acad Sci 94 1961 844 860
55. D.M. Maxwell, K.M. Brecht, and B.L. O'Neill The effect of carboxylesterase inhibition on interspecies differences in soman toxicity Toxicol Lett 39 1 1987 35 42
56. C.Y. Quon, and H.F. Stampfli Biochemical properties of blood esmolol esterase Drug Metab Dispos 13 4 1985 420 424
57. H. Kusumoto, S. Hirosawa, J.P. Salier, F.S. Hagen, and K. Kurachi Human genes for complement components C1r and C1s in a close tail-to-tail arrangement Proc Natl Acad Sci USA 85 19 1988 7307 7311
58. P. Masson, M.T. Froment, P.L. Fortier, J.E. Visicchio, C.F. Bartels, and O. Lockridge Butyrylcholinesterase-catalysed hydrolysis of aspirin, a negatively charged ester, and aspirin-related neutral esters Biochim Biophys Acta 1387 1-2 1998 41 52
59. K.D. Rainsford, N.L. Ford, P.M. Brooks, and H.M. Watson Plasma aspirin esterases in normal individuals, patients with alcoholic liver disease and rheumatoid arthritis: characterization and the importance of the enzymic components Eur J Clin Invest 10 5 1980 413 420
60. M. Morikawa, M. Inoue, M. Tsuboi, and M. Sugiura Studies on aspirin esterase of human serum Jpn J Pharmacol 29 4 1979 581 586
61. J.F. Gilmer, L.M. Moriarty, M.N. Lally, and J.M. Clancy Isosorbide-based aspirin prodrugs. II. Hydrolysis kinetics of isosorbide diaspirinate Eur J Pharm Sci 16 4-5 2002 297 304
62. A. Tunek, and L.A. Svensson Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood Drug Metab Dispos 16 5 1988 759 764
63. D.J. Stewart, T. Inaba, B.K. Tang, and W. Kalow Hydrolysis of cocaine in human plasma by cholinesterase Life Sci 20 9 1977 1557 1563
64. T.J. Lynch, C.E. Mattes, A. Singh, R.M. Bradley, R.O. Brady, and K.L. Dretchen Cocaine detoxification by human plasma butyrylcholinesterase Toxicol Appl Pharmacol 145 2 1997 363 371
65. C.L. Morton, R.M. Wadkins, M.K. Danks, and P.M. Potter The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesterase Cancer Res 59 7 1999 1458 1463
66. C.Y. Quon, and H.F. Stampfli Biochemical characterization of flestolol esterase Res Commun Chem Pathol Pharmacol 81 3 1993 309 322
67. N. Chapuis, C. Bruhlmann, M. Reist, P.A. Carrupt, J.M. Mayer, and B. Testa The esterase-like activity of serum albumin may be due to cholinesterase contamination Pharm Res 18 10 2001 1435 1439
68. C. De Vriese, F. Gregoire, R. Lema-Kisoka, M. Waelbroeck, P. Robberecht, and C. Delporte Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites Endocrinology 145 11 2004 4997 5005
69. O. Lockridge, N. Mottershaw-Jackson, H.W. Eckerson, and B.N. La Du Hydrolysis of diacetylmorphine (heroin) by human serum cholinesterase J Pharmacol Exp Ther 215 1 1980 1 8
70. F.F. Foldes, P.G. McNall, C.H. Ellis, D.L. Davis, and A.L. Wnuck Substrate competition procaine and succinylcholine diiodide for plasma cholinesterase Science 117 3041 1953 383 386
71. O. Lockridge Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine Pharmacol Ther 47 1 1990 35 60
72. D. Ostergaard, F.S. Jensen, L.T. Skovgaard, and J. Viby-Mogensen Dose-response relationship for mivacurium in patients with phenotypically abnormal plasma cholinesterase activity Acta Anaesthesiol Scand 39 8 1995 1016 1018
73. J.J. Savarese, H.H. Ali, S.J. Basta, P.B. Embree, R.P. Scott, and N. Sunder The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug Anesthesiology 68 5 1988 723 732
74. C. Meyers, O. Lockridge, and B.N. La Du Hydrolysis of methylprednisolone acetate by human serum cholinesterase Drug Metab Dispos 10 3 1982 279 280
75. J.E. O'Brien, V. Abbey, O. Hinsvark, J. Perel, and M. Finster Metabolism and measurement of chloroprocaine, an ester-type local anesthetic J Pharm Sci 68 1 1979 75 78
76. C.E. Becker Cholinesterase genotype and hydrolysis of choline esters, procaine and tetracaine Hum Hered 23 4 1973 394 399
77. S. Billecke, D. Draganov, R. Counsell, P. Stetson, C. Watson, and C. Hsu Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters Drug Metab Dispos 28 11 2000 1335 1342
78. J. Ortigoza-Ferado, R.J. Richter, S.K. Hornung, A.G. Motulsky, and C.E. Furlong Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin Am J Hum Genet 36 2 1984 295 305
79. H.G. Davies, R.J. Richter, M. Keifer, C.A. Broomfield, J. Sowalla, and C.E. Furlong The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin Nat Genet 14 3 1996 334 336
80. K. Tougou, A. Nakamura, S. Watanabe, Y. Okuyama, and A. Morino Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent Drug Metab Dispos 26 4 1998 355 359
81. K. Biggadike, R.M. Angell, C.M. Burgess, R.M. Farrell, A.P. Hancock, and A.J. Harker Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism J Med Chem 43 1 2000 19 21
82. D. Kiderlen, P. Eyer, and F. Worek Formation and disposition of diethylphosphoryl-obidoxime, a potent anticholinesterase that is hydrolyzed by human paraoxonase (PON1) Biochem Pharmacol 69 12 2005 1853 1867
83. R.P. Agarwal, M. Phillips, R.A. McPherson, and P. Hensley Serum albumin and the metabolism of disulfiram Biochem Pharmacol 35 19 1986 3341 3347
84. C.H. Kwon, K. Maddison, L. LoCastro, and R.F. Borch Accelerated decomposition of 4-hydroxycyclophosphamide by human serum albumin Cancer Res 47 6 1987 1505 1508
85. N. Dubois-Presle, F. Lapicque, M.H. Maurice, S. Fournel-Gigleux, J. Magdalou, and M. Abiteboul Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide Mol Pharmacol 47 3 1995 647 653
86. M.A. Sogorb, V. Carrera, and E. Vilanova Hydrolysis of carbaryl by human serum albumin Arch Toxicol 78 11 2004 629 634
87. K.N. Gan, A. Smolen, H.W. Eckerson, and B.N. La Du Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities Drug Metab Dispos 19 1 1991 100 106
88. M.C. Blatter Garin, C. Abbott, S. Messmer, M. Mackness, P. Durrington, and D. Pometta Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations Biochem J 304 Pt 2 1994 549 554
89. M.N. Oda, J.K. Bielicki, T.T. Ho, T. Berger, E.M. Rubin, and T.M. Forte Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins Biochem Biophys Res Commun 290 3 2002 921 927
90. T. Peters Jr. All about albumin. Biochemistry, genetics, and medical applications 1996 Academic Press Ltd. London
91. U. Lexow, A. Ronai, and O. von Deimling Purification and characterization of esterase 2B of the house mouse, Mus musculus Eur J Biochem 107 1 1980 123 130
92. P. Masson A naturally occurring molecular form of human plasma cholinesterase is an albumin conjugate Biochim Biophys Acta 998 3 1989 258 266